Synthesis of 9-Aminoacridine Derivatives as Anti-Alzheimer Agents

In the present study, some 9-aminoacridine derivatives have been synthesized by condensation of 9-aminoacridine with substituted phenacyl, benzoyl, and benzyl halides (RM1-RM6). Compounds were investigated for acetylcholinesterase and butyrylcholinesterase inhibition potential, considering these enz...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of Alzheimer's disease and other dementias 2016-05, Vol.31 (3), p.263-269
Hauptverfasser: Munawar, Rabya, Mushtaq, Nousheen, Arif, Sadia, Ahmed, Ahsaan, Akhtar, Shamim, Ansari, Sumaira, Meer, Sadia, Saify, Zafar S., Arif, Muhammad
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 269
container_issue 3
container_start_page 263
container_title American journal of Alzheimer's disease and other dementias
container_volume 31
creator Munawar, Rabya
Mushtaq, Nousheen
Arif, Sadia
Ahmed, Ahsaan
Akhtar, Shamim
Ansari, Sumaira
Meer, Sadia
Saify, Zafar S.
Arif, Muhammad
description In the present study, some 9-aminoacridine derivatives have been synthesized by condensation of 9-aminoacridine with substituted phenacyl, benzoyl, and benzyl halides (RM1-RM6). Compounds were investigated for acetylcholinesterase and butyrylcholinesterase inhibition potential, considering these enzymes playing a key role in Alzheimer’s disease. All derivatives showed better inhibition of enzymes than the standard galantamine, whereas except RM4, all exhibit better results than tacrine, a well-known acridine derivative used for the treatment of Alzheimer’s disease.
doi_str_mv 10.1177/1533317515603115
format Article
fullrecord <record><control><sourceid>sage_AFRWT</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10852649</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1533317515603115</sage_id><sourcerecordid>10.1177_1533317515603115</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-be1c094b3657ae717ac34302c89256bcbbbeb1e022f48895d4e586b8047521a63</originalsourceid><addsrcrecordid>eNp1kMtKAzEUhoMotlb3rmReIJrrJLOSoV6h4EJdhyQ906Z0ZkoyLdSnd0q1qODqHPhv8CF0Sck1pUrdUMk5p0pSmRNOqTxCQ1pwjZni9Lj_exnv9AE6S2lBiJBak1M0YDnXshByiMrXbdPNIYWUtVVW4LIOTWt9DNPQQHYHMWxsFzaQMpuysukCLpcfcwg1xKycQdOlc3RS2WWCi687Qu8P92_jJzx5eXwelxPsBZcddkA9KYTjuVQWFFXWc8EJ87pgMnfeOQeOAmGsEloXcipA6txpIpRk1OZ8hG73vau1q2Hq--1ol2YVQ23j1rQ2mN9KE-Zm1m4MJVqyXBR9A9k3-NimFKE6hCkxO57mL88-cvVz9BD4Btgb8N6Q7AzMol3Hpofwf-EnbnJ9TA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthesis of 9-Aminoacridine Derivatives as Anti-Alzheimer Agents</title><source>SAGE Journals</source><creator>Munawar, Rabya ; Mushtaq, Nousheen ; Arif, Sadia ; Ahmed, Ahsaan ; Akhtar, Shamim ; Ansari, Sumaira ; Meer, Sadia ; Saify, Zafar S. ; Arif, Muhammad</creator><creatorcontrib>Munawar, Rabya ; Mushtaq, Nousheen ; Arif, Sadia ; Ahmed, Ahsaan ; Akhtar, Shamim ; Ansari, Sumaira ; Meer, Sadia ; Saify, Zafar S. ; Arif, Muhammad</creatorcontrib><description>In the present study, some 9-aminoacridine derivatives have been synthesized by condensation of 9-aminoacridine with substituted phenacyl, benzoyl, and benzyl halides (RM1-RM6). Compounds were investigated for acetylcholinesterase and butyrylcholinesterase inhibition potential, considering these enzymes playing a key role in Alzheimer’s disease. All derivatives showed better inhibition of enzymes than the standard galantamine, whereas except RM4, all exhibit better results than tacrine, a well-known acridine derivative used for the treatment of Alzheimer’s disease.</description><identifier>ISSN: 1533-3175</identifier><identifier>EISSN: 1938-2731</identifier><identifier>DOI: 10.1177/1533317515603115</identifier><identifier>PMID: 26385945</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Alzheimer Disease - drug therapy ; Alzheimer Disease - enzymology ; Aminacrine - chemical synthesis ; Cholinesterase Inhibitors - chemical synthesis ; Current Topics in Research ; Humans ; In Vitro Techniques</subject><ispartof>American journal of Alzheimer's disease and other dementias, 2016-05, Vol.31 (3), p.263-269</ispartof><rights>The Author(s) 2015</rights><rights>The Author(s) 2015.</rights><rights>The Author(s) 2015 2015 SAGE Publications</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-be1c094b3657ae717ac34302c89256bcbbbeb1e022f48895d4e586b8047521a63</citedby><cites>FETCH-LOGICAL-c435t-be1c094b3657ae717ac34302c89256bcbbbeb1e022f48895d4e586b8047521a63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852649/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852649/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,21966,27853,27924,27925,44945,45333,53791,53793</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/1533317515603115?utm_source=summon&amp;utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26385945$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Munawar, Rabya</creatorcontrib><creatorcontrib>Mushtaq, Nousheen</creatorcontrib><creatorcontrib>Arif, Sadia</creatorcontrib><creatorcontrib>Ahmed, Ahsaan</creatorcontrib><creatorcontrib>Akhtar, Shamim</creatorcontrib><creatorcontrib>Ansari, Sumaira</creatorcontrib><creatorcontrib>Meer, Sadia</creatorcontrib><creatorcontrib>Saify, Zafar S.</creatorcontrib><creatorcontrib>Arif, Muhammad</creatorcontrib><title>Synthesis of 9-Aminoacridine Derivatives as Anti-Alzheimer Agents</title><title>American journal of Alzheimer's disease and other dementias</title><addtitle>Am J Alzheimers Dis Other Demen</addtitle><description>In the present study, some 9-aminoacridine derivatives have been synthesized by condensation of 9-aminoacridine with substituted phenacyl, benzoyl, and benzyl halides (RM1-RM6). Compounds were investigated for acetylcholinesterase and butyrylcholinesterase inhibition potential, considering these enzymes playing a key role in Alzheimer’s disease. All derivatives showed better inhibition of enzymes than the standard galantamine, whereas except RM4, all exhibit better results than tacrine, a well-known acridine derivative used for the treatment of Alzheimer’s disease.</description><subject>Alzheimer Disease - drug therapy</subject><subject>Alzheimer Disease - enzymology</subject><subject>Aminacrine - chemical synthesis</subject><subject>Cholinesterase Inhibitors - chemical synthesis</subject><subject>Current Topics in Research</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><issn>1533-3175</issn><issn>1938-2731</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtKAzEUhoMotlb3rmReIJrrJLOSoV6h4EJdhyQ906Z0ZkoyLdSnd0q1qODqHPhv8CF0Sck1pUrdUMk5p0pSmRNOqTxCQ1pwjZni9Lj_exnv9AE6S2lBiJBak1M0YDnXshByiMrXbdPNIYWUtVVW4LIOTWt9DNPQQHYHMWxsFzaQMpuysukCLpcfcwg1xKycQdOlc3RS2WWCi687Qu8P92_jJzx5eXwelxPsBZcddkA9KYTjuVQWFFXWc8EJ87pgMnfeOQeOAmGsEloXcipA6txpIpRk1OZ8hG73vau1q2Hq--1ol2YVQ23j1rQ2mN9KE-Zm1m4MJVqyXBR9A9k3-NimFKE6hCkxO57mL88-cvVz9BD4Btgb8N6Q7AzMol3Hpofwf-EnbnJ9TA</recordid><startdate>20160501</startdate><enddate>20160501</enddate><creator>Munawar, Rabya</creator><creator>Mushtaq, Nousheen</creator><creator>Arif, Sadia</creator><creator>Ahmed, Ahsaan</creator><creator>Akhtar, Shamim</creator><creator>Ansari, Sumaira</creator><creator>Meer, Sadia</creator><creator>Saify, Zafar S.</creator><creator>Arif, Muhammad</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20160501</creationdate><title>Synthesis of 9-Aminoacridine Derivatives as Anti-Alzheimer Agents</title><author>Munawar, Rabya ; Mushtaq, Nousheen ; Arif, Sadia ; Ahmed, Ahsaan ; Akhtar, Shamim ; Ansari, Sumaira ; Meer, Sadia ; Saify, Zafar S. ; Arif, Muhammad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-be1c094b3657ae717ac34302c89256bcbbbeb1e022f48895d4e586b8047521a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Alzheimer Disease - drug therapy</topic><topic>Alzheimer Disease - enzymology</topic><topic>Aminacrine - chemical synthesis</topic><topic>Cholinesterase Inhibitors - chemical synthesis</topic><topic>Current Topics in Research</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Munawar, Rabya</creatorcontrib><creatorcontrib>Mushtaq, Nousheen</creatorcontrib><creatorcontrib>Arif, Sadia</creatorcontrib><creatorcontrib>Ahmed, Ahsaan</creatorcontrib><creatorcontrib>Akhtar, Shamim</creatorcontrib><creatorcontrib>Ansari, Sumaira</creatorcontrib><creatorcontrib>Meer, Sadia</creatorcontrib><creatorcontrib>Saify, Zafar S.</creatorcontrib><creatorcontrib>Arif, Muhammad</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of Alzheimer's disease and other dementias</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Munawar, Rabya</au><au>Mushtaq, Nousheen</au><au>Arif, Sadia</au><au>Ahmed, Ahsaan</au><au>Akhtar, Shamim</au><au>Ansari, Sumaira</au><au>Meer, Sadia</au><au>Saify, Zafar S.</au><au>Arif, Muhammad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of 9-Aminoacridine Derivatives as Anti-Alzheimer Agents</atitle><jtitle>American journal of Alzheimer's disease and other dementias</jtitle><addtitle>Am J Alzheimers Dis Other Demen</addtitle><date>2016-05-01</date><risdate>2016</risdate><volume>31</volume><issue>3</issue><spage>263</spage><epage>269</epage><pages>263-269</pages><issn>1533-3175</issn><eissn>1938-2731</eissn><abstract>In the present study, some 9-aminoacridine derivatives have been synthesized by condensation of 9-aminoacridine with substituted phenacyl, benzoyl, and benzyl halides (RM1-RM6). Compounds were investigated for acetylcholinesterase and butyrylcholinesterase inhibition potential, considering these enzymes playing a key role in Alzheimer’s disease. All derivatives showed better inhibition of enzymes than the standard galantamine, whereas except RM4, all exhibit better results than tacrine, a well-known acridine derivative used for the treatment of Alzheimer’s disease.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>26385945</pmid><doi>10.1177/1533317515603115</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 1533-3175
ispartof American journal of Alzheimer's disease and other dementias, 2016-05, Vol.31 (3), p.263-269
issn 1533-3175
1938-2731
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10852649
source SAGE Journals
subjects Alzheimer Disease - drug therapy
Alzheimer Disease - enzymology
Aminacrine - chemical synthesis
Cholinesterase Inhibitors - chemical synthesis
Current Topics in Research
Humans
In Vitro Techniques
title Synthesis of 9-Aminoacridine Derivatives as Anti-Alzheimer Agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T02%3A43%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%209-Aminoacridine%20Derivatives%20as%20Anti-Alzheimer%20Agents&rft.jtitle=American%20journal%20of%20Alzheimer's%20disease%20and%20other%20dementias&rft.au=Munawar,%20Rabya&rft.date=2016-05-01&rft.volume=31&rft.issue=3&rft.spage=263&rft.epage=269&rft.pages=263-269&rft.issn=1533-3175&rft.eissn=1938-2731&rft_id=info:doi/10.1177/1533317515603115&rft_dat=%3Csage_AFRWT%3E10.1177_1533317515603115%3C/sage_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/26385945&rft_sage_id=10.1177_1533317515603115&rfr_iscdi=true